{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:38:50Z","timestamp":1792719530606,"version":"4.5.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.clinbiochem.2026.111217","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T06:43:20Z","timestamp":1791441800000},"page":"111217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Reframing liver test abnormalities after AAV gene therapy: a mechanistic diagnostic framework"],"prefix":"10.1016","volume":"146","author":[{"given":"Brandon Michael","family":"Henry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Benichou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melvin Y.","family":"Rincon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Lippi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"D'Antiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2026.111217_bb0005","series-title":"Approved Cellular and Gene Therapy Products","author":"C. for B.E. and Research","year":"2025"},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0010","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29305","article-title":"Infusion reactions to adeno-associated virus (AAV)-based gene therapy: mechanisms, diagnostics, treatment and review of the literature","volume":"95","author":"Notarte","year":"2023","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0015","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s11901-023-00624-5","article-title":"Hepatotoxicity in adeno-associated viral vector gene therapy","volume":"22","author":"Jagadisan","year":"2023","journal-title":"Curr. Hepatol. Rep."},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0020","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1016\/j.ymthe.2023.10.015","article-title":"Lethal immunotoxicity in high-dose systemic AAV therapy","volume":"31","author":"Duan","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.gastha.2025.100681","article-title":"Hepatic manifestations following gene therapy","volume":"4","author":"Roy","year":"2025","journal-title":"Gastro Hep Adv"},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0030","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1542\/peds.2010-0929","article-title":"Serum transaminase levels in boys with Duchenne and Becker muscular dystrophy","volume":"127","author":"McMillan","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0035","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1111\/liv.15239","article-title":"CureCN consortium, Disease burden and management of Crigler-Najjar syndrome: report of a world registry","volume":"42","author":"Aronson","year":"2022","journal-title":"Liver Int."},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.975803","article-title":"Immunogenicity and toxicity of AAV gene therapy","volume":"13","author":"Ertl","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0045","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/hep.32689","article-title":"AASLD practice guidance on drug, herbal, and dietary supplement-induced liver injury","volume":"77","author":"Fontana","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0050","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1111\/liv.16065","article-title":"Drug-induced liver injury related to gene therapy: a new challenge to be managed","volume":"44","author":"Larrey","year":"2024","journal-title":"Liver Int."},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0055","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0009-8981(02)00341-8","article-title":"New IFCC reference procedures for the determination of catalytic activity concentrations of five enzymes in serum: preliminary upper reference limits obtained in hospitalized subjects","volume":"327","author":"Schumann","year":"2003","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0060","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.yrtph.2015.07.013","article-title":"Children\u2019s liver chemistries vary with age and gender and require customized pediatric reference ranges","volume":"73","author":"Stirnadel-Farrant","year":"2015","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/cells12050785","article-title":"Various AAV serotypes and their applications in gene therapy: an overview","volume":"12","author":"Issa","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0070","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1177\/01926233221101309","article-title":"Intrathecal sc-AAV9-CB-GFP: systemic distribution predominates following single-dose Administration in Cynomolgus Macaques","volume":"50","author":"Meseck","year":"2022","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0075","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/978-1-4939-9139-6_20","article-title":"AAV-mediated gene delivery to the liver: overview of current technologies and methods","volume":"1950","author":"Palaschak","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0080","series-title":"FDA Approves New Safety Warning and Revised Indication that Limits Use for Elevidys Following Reports of Fatal Liver Injury","year":"2025"},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0085","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1016\/j.ymthe.2023.07.020","article-title":"Liver injury in cynomolgus monkeys following intravenous and intrathecal scAAV9 gene therapy delivery","volume":"31","author":"Hudry","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0090","doi-asserted-by":"crossref","DOI":"10.1172\/JCI143780","article-title":"Overcoming innate immune barriers that impede AAV gene therapy vectors","volume":"131","author":"Muhuri","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0095","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.omtm.2020.07.005","article-title":"Induction of ER stress by an AAV5 BDD FVIII construct is dependent on the strength of the hepatic-specific promoter","volume":"18","author":"Fong","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0100","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jtha.2023.12.005","article-title":"Deciphering conundrums of adeno-associated virus liver-directed gene therapy: focus on hemophilia","volume":"22","author":"Pierce","year":"2024","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0105","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa1407309","article-title":"Long-term safety and efficacy of factor IX gene therapy in hemophilia B","volume":"371","author":"Nathwani","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0110","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nm1358","article-title":"Successful transduction of liver in hemophilia by AAV-factor IX and limitations imposed by the host immune response","volume":"12","author":"Manno","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pediatrneurol.2024.11.005","article-title":"Acute liver injury following Delandistrogene Moxeparvovec gene therapy requiring intravenous immunoglobulin","volume":"163","author":"Duvuru","year":"2025","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0120","series-title":"FDA Investigating Deaths Due to Acute Liver Failure in Non-ambulatory Duchenne Muscular Dystrophy Patients Following ELEVIDYS","author":"C. for B.E. and Research","year":"2025"},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0125","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6484610","article-title":"Ratio of creatine kinase to alanine aminotransferase as a biomarker of acute liver injury in dystrophinopathy","volume":"2018","author":"Wang","year":"2018","journal-title":"Dis. Markers"},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0130","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.ymthe.2024.02.002","article-title":"High-dose systemic adeno-associated virus vector administration causes liver and sinusoidal endothelial cell injury","volume":"32","author":"Hordeaux","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0135","doi-asserted-by":"crossref","DOI":"10.1172\/JCI173510","article-title":"Thrombotic microangiopathy following systemic AAV administration is dependent on anti-capsid antibodies","volume":"134","author":"Salabarria","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0140","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/toxsci\/kfae143","article-title":"Serum glutamate dehydrogenase activity enables sensitive and specific diagnosis of hepatocellular injury in humans","volume":"203","author":"Aubrecht","year":"2025","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229753","article-title":"Serum glutamate dehydrogenase activity enables early detection of liver injury in subjects with underlying muscle impairments","volume":"15","author":"Schomaker","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0150","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1503\/cmaj.1040752","article-title":"Liver enzyme alteration: a guide for clinicians","volume":"172","author":"Giannini","year":"2005","journal-title":"CMAJ"},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0155","series-title":"Clinical methods: the history, physical, and laboratory examinations","article-title":"Aminotransferases","author":"Vroon","year":"1990"},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0160","series-title":"StatPearls","article-title":"Liver Function Tests","author":"Lala","year":"2025"},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mpaic.2017.10.003","article-title":"Laboratory tests in liver failure","volume":"19","author":"Lui","year":"2018","journal-title":"Anaesthesia & Intensive Care Medicine"},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0170","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004821","article-title":"The aspartate aminotransferase-to-alanine aminotransferase ratio predicts all-cause and cardiovascular mortality in patients with type 2 diabetes","volume":"95","author":"Zoppini","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0175","first-page":"30","article-title":"What is the real function of the liver \u2018function\u2019 tests?","volume":"81","author":"Hall","year":"2012","journal-title":"Ulster Med. J."},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0180","doi-asserted-by":"crossref","first-page":"6920","DOI":"10.1038\/s41598-023-34263-z","article-title":"Change in skeletal muscle mass is associated with hepatic steatosis in nonalcoholic fatty liver disease","volume":"13","author":"Jo","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0185","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000028443","article-title":"Characteristics of peripheral blood gamma-glutamyl transferase in different liver diseases","volume":"101","author":"Xing","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0190","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10519-013-9593-y","article-title":"The genetic architecture of liver enzyme levels: GGT, ALT and AST","volume":"43","author":"van Beek","year":"2013","journal-title":"Behav. Genet."},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0195","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1177\/0883073808314365","article-title":"Fidelity of gamma-glutamyl transferase (GGT) in differentiating skeletal muscle from liver damage","volume":"23","author":"Rosales","year":"2008","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0200","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1038\/s41591-025-03750-3","article-title":"AAV mini-dystrophin gene therapy for Duchenne muscular dystrophy: a phase 1b trial","volume":"31","author":"Butterfield","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0205","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41591-024-03304-z","article-title":"AAV gene therapy for Duchenne muscular dystrophy: the EMBARK phase 3 randomized trial","volume":"31","author":"Mendell","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0210","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/mus.28431","article-title":"Serum creatine kinase and transaminase levels in Duchenne and Becker muscular dystrophies","volume":"72","author":"Rohlenov\u00e1","year":"2025","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0215","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.aohep.2019.08.004","article-title":"The relative expression of hepatocellular and cholestatic liver enzymes in adult patients with liver disease","volume":"19","author":"Iluz-Freundlich","year":"2020","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0225","article-title":"Clinical implications of conjugated vs. direct bilirubin testing: analytical limits and clinical consequences","author":"Sonntag","year":"2025","journal-title":"Diagnosis"},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0230","article-title":"Increased INR values predict accelerating deterioration and high short-term mortality among patients hospitalized with cirrhosis or advanced fibrosis","volume":"8","author":"Wang","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0235","series-title":"StatPearls","article-title":"Hypoalbuminemia","author":"Gounden","year":"2023"},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0240","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.3748\/wjg.v26.i10.1020","article-title":"Abnormal liver function tests associated with severe rhabdomyolysis","volume":"26","author":"Lim","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0245","doi-asserted-by":"crossref","first-page":"306","DOI":"10.5535\/arm.2017.41.2.306","article-title":"Correlation of serum creatine kinase level with pulmonary function in Duchenne muscular dystrophy","volume":"41","author":"Oh","year":"2017","journal-title":"Ann. Rehabil. Med."},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0250","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/ajg.2014.131","article-title":"Practice parameters Committee of the American College of gastroenterology, ACG clinical guideline: the diagnosis and management of idiosyncratic drug-induced liver injury","volume":"109","author":"Chalasani","year":"2014","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0255","series-title":"Fourth boy dies in trial of Astellas gene therapy candidate","author":"Philippidis","year":"2021"},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0260","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/hep.28944","article-title":"Pediatric acute liver failure of undetermined cause: a research workshop","volume":"65","author":"Alonso","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0265","series-title":"Pediatric hepatology and liver transplantation","first-page":"145","article-title":"Acute liver failure in children","author":"Shanmugam","year":"2018"},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0270","doi-asserted-by":"crossref","DOI":"10.1177\/22143602261424971","article-title":"Sirolimus for the treatment of steroid-refractory hepatotoxicity following AAV gene therapy in patients with Duchenne muscular dystrophy","author":"Leon-Astudillo","year":"2026","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0275","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jhep.2020.11.001","article-title":"Hepatotoxicity following administration of onasemnogene abeparvovec (AVXS-101) for the treatment of spinal muscular atrophy","volume":"74","author":"Chand","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0280","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1016\/j.ymthe.2024.07.016","article-title":"A systematic review of immunosuppressive protocols used in AAV gene therapy for monogenic disorders","volume":"32","author":"Vrellaku","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0285","article-title":"Elevated transaminases: does it always warrant a liver biopsy? Lessons learned from Pompe disease","volume":"66","author":"Khazzeka","year":"2025","journal-title":"JIMD Rep."},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0290","doi-asserted-by":"crossref","first-page":"987","DOI":"10.3233\/JND-221666","article-title":"Biomarkers in Duchenne muscular dystrophy: current status and future directions","volume":"10","author":"Fortunato","year":"2023","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0295","doi-asserted-by":"crossref","first-page":"719","DOI":"10.47102\/annals-acadmedsg.V29N6p719","article-title":"Transaminitis in Duchenne\u2019s muscular dystrophy","volume":"29","author":"Tay","year":"2000","journal-title":"Ann. Acad. Med. Singap."},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0300","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1056\/NEJMoa1108046","article-title":"Adenovirus-associated virus vector-mediated gene transfer in hemophilia B","volume":"365","author":"Nathwani","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0305","doi-asserted-by":"crossref","first-page":"11343","DOI":"10.1128\/JVI.76.22.11343-11349.2002","article-title":"A limited number of transducible hepatocytes restricts a wide-range linear vector dose response in recombinant adeno-associated virus-mediated liver transduction","volume":"76","author":"Nakai","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0310","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1056\/NEJMoa2214084","article-title":"Gene therapy in patients with the Crigler\u2013Najjar syndrome","volume":"389","author":"D\u2019Antiga","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0315","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/hep.29542","article-title":"New pediatric percentiles of liver enzyme serum levels (alanine aminotransferase, aspartate aminotransferase, \u03b3-glutamyltransferase): effects of age, sex, body mass index, and pubertal stage","volume":"68","author":"Bussler","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0320","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/pr.2015.247","article-title":"Inherited disorders of bilirubin clearance","volume":"79","author":"Memon","year":"2016","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0325","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1519\/JSC.0000000000002167","article-title":"High-intensity exercise induced oxidative stress and skeletal muscle damage in postpubertal boys and girls: a comparative study","volume":"32","author":"Pal","year":"2018","journal-title":"J. Strength Cond. Res."},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0330","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.1007\/s00431-023-05248-x","article-title":"Infant liver biochemistry is different than current laboratory accepted norms","volume":"182","author":"Kolho","year":"2023","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022732","article-title":"Effect of constitution on mass of individual organs and their association with metabolic rate in humans--a detailed view on allometric scaling","volume":"6","author":"M\u00fcller","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0340","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev.pharmtox.48.113006.094708","article-title":"Mechanism-based concepts of size and maturity in pharmacokinetics","volume":"48","author":"Anderson","year":"2008","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0345","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/pan.13272","article-title":"What is the best size predictor for dose in the obese child?","volume":"27","author":"Anderson","year":"2017","journal-title":"Paediatr. Anaesth."},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0350","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1111\/bcp.14736","article-title":"MicroRNA-122 and cytokeratin-18 have potential as biomarkers of drug-induced liver injury in European and African patients on treatment for mycobacterial infection","volume":"87","author":"Rupprechter","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.clinbiochem.2026.111217_bb0355","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1007\/s00204-021-03121-0","article-title":"The application of cytokeratin-18 as a biomarker for drug-induced liver injury","volume":"95","author":"Korver","year":"2021","journal-title":"Arch. Toxicol."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912026001505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912026001505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:19:03Z","timestamp":1792718343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912026001505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":70,"alternative-id":["S0009912026001505"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2026.111217","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reframing liver test abnormalities after AAV gene therapy: a mechanistic diagnostic framework","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2026.111217","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111217"}}